Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2010 2
2011 1
2012 2
2015 1
2017 1
2018 1
2020 3
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.
Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA; STOP2 Investigators. Goss CH, et al. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC. Am J Respir Crit Care Med. 2021. PMID: 34469706 Free PMC article. Clinical Trial.
Methods: STOP2 (Standardized Treatment of Pulmonary Exacerbations 2) was a multicenter, randomized, controlled clinical trial in exacerbations among adults with CF. ...For those with less improvement after one week, 21 days is not superior to 14 days. Clin
Methods: STOP2 (Standardized Treatment of Pulmonary Exacerbations 2) was a multicenter, randomized, controlled clinical tri
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
Parkins MD, Elborn JS. Parkins MD, et al. J Antimicrob Chemother. 2010 Sep;65(9):1853-61. doi: 10.1093/jac/dkq245. Epub 2010 Jul 6. J Antimicrob Chemother. 2010. PMID: 20605846 Review.
While several antibiotics have recently been approved or are close to approval for clinical use, frequently their emphasis has been for Gram-positive, and specifically MRSA-related, disease. ...This article reviews the spectrum of activity, pharmacokinetics and clinical
While several antibiotics have recently been approved or are close to approval for clinical use, frequently their emphasis has been f …
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
Cogen JD, Faino AV, Onchiri F, Gibson RL, Hoffman LR, Kronman MP, Rosenfeld M, Nichols DP. Cogen JD, et al. Ann Am Thorac Soc. 2021 Feb;18(2):266-272. doi: 10.1513/AnnalsATS.202002-176OC. Ann Am Thorac Soc. 2021. PMID: 32810412 Free PMC article.
Recent evidence has identified a potential antagonistic relationship between AZM and tobramycin.Objectives: To determine whether, among PEx treated with intravenous tobramycin, concomitant AZM use is associated with worse clinical outcomes.Methods: Retrospective cohort stu …
Recent evidence has identified a potential antagonistic relationship between AZM and tobramycin.Objectives: To determine whether, among PEx …
Iron homeostasis during cystic fibrosis pulmonary exacerbation.
Gifford AH, Moulton LA, Dorman DB, Olbina G, Westerman M, Parker HW, Stanton BA, O'Toole GA. Gifford AH, et al. Clin Transl Sci. 2012 Aug;5(4):368-73. doi: 10.1111/j.1752-8062.2012.00417.x. Epub 2012 Jun 1. Clin Transl Sci. 2012. PMID: 22883617 Free PMC article. Clinical Trial.
Approaches for Genetic Discoveries in the Skin Commensal and Pathogenic Malassezia Yeasts.
Ianiri G, Heitman J. Ianiri G, et al. Front Cell Infect Microbiol. 2020 Aug 7;10:393. doi: 10.3389/fcimb.2020.00393. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32850491 Free PMC article. Review.
More recently, associations of Malassezia with Crohn's disease, pancreatic ductal adenocarcinoma, and cystic fibrosis pulmonary exacerbation have been reported. The increasing availability of genomic and molecular tools have played a crucial role in un …
More recently, associations of Malassezia with Crohn's disease, pancreatic ductal adenocarcinoma, and cystic fibrosis pulmo
Timing of Spirometry May Impact Hospital Length of Stay for Cystic Fibrosis Pulmonary Exacerbation.
Krivchenia K, Tumin D, Nemastil CJ, Tobias JD, Hayes D Jr. Krivchenia K, et al. Lung. 2018 Apr;196(2):207-211. doi: 10.1007/s00408-018-0082-1. Epub 2018 Jan 18. Lung. 2018. PMID: 29349537
After excluding patient encounters with missing data on covariates, random-effects linear regression was used to predict LOS as a function of days to first pulmonary function testing (PFT), which was spirometry for our study. ...
After excluding patient encounters with missing data on covariates, random-effects linear regression was used to predict LOS as a fun …
15 results